Work

High-dose imatinib mesylate treatment in patients (Pts) with untreated early chronic phase (CP) chronic myeloid leukemia (CML): 2.5-year follow-up

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.6535

Authors: E. Aoki, H. Kantarjian, S. O’Brien, M. Talpaz, F. Giles, G. Garcia-Manero, W. Wierda, S. Verstovsek, D. Jones, R. Luthra, J. Cortes

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2301293935

Cites:

Cited by: 34

Related to: 10